IPO Ideas logoIPO Ideas
GMPSubscriptionOFS
About Us
Menu

IPO market

  • Current IPOsOpen and live issues
  • Closed IPOsPast issues and listing outcomes
  • Upcoming IPOsNew issues and opening dates
  • IPO CalendarKey dates in chronological order
GMPGrey market premium
SubscriptionBid status by category
OFSOffer for Sale

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

About Us
  1. IPO
  2. /Sudeep Pharma Limited IPO
IPO Ideas

Follow us on

IPO Ideas is 100% Safe and Secure!

Your Trust, Our Priority

Empowering You with Confidence

Welcome to IPO Ideas— your trusted gateway to IPO bidding and smart investing. We're a passionate team dedicated to making equity investing simpler, faster, and more secure for everyone.

Our mission is to empower retail investors with a user-friendly platform that brings clarity, convenience, and control to the IPO process. From secure bidding to live GMP tracking and allotment updates — everything you need is just a few clicks away.

IPOs
  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Calendar
Tools
  • GMP
  • OFS
  • Subscription
Products
  • IPO Ideas
  • Unlisted Ideas
Company
  • About Us
  • Customer Service
  • Fraud Awareness
Legal
  • Privacy Policy
  • Terms & Conditions
  • Legal & Regulatory

Advertiser Disclosure

G2RS Verified under Exempt Financial Services Advertiser

We offer two types of advertising on our website: display advertisements related to brokers and IPOs, and affiliate links that redirect users to a stock broker's website.

We have partnerships with brokers, and when you become a client of a broker through our affiliate links, we may receive an affiliate commission. We do not work with individual clients after you click on affiliate links.

We do not provide tips, recommendations, or buy/sell calls. All information published on this website is for educational and knowledge sharing purposes only. Our broker reviews are completely unbiased, and the final choice remains yours.

We provide up-to-date information on IPOs, buybacks, NCDs, SGBs, and rights issues. GMP data is displayed strictly for informational and news purposes only. We do not work with or trade through GMP operators.

COPYRIGHT ©2026 IPO Ideas • All rights reserved

Sudeep Pharma IPO logo

Sudeep Pharma IPO

Mainboard • BSE,NSE

—
Listed at
730
+23.10%

Sudeep Pharma IPO is a Mainboard IPO. Issue size is 895.00 Cr. Price band is ₹563 to ₹593 per share. Minimum investment is ₹14,825. Lot size is 25 shares. Open from 21 Nov 2025 to 25 Nov 2025. on 26 Nov 2025. Listing on 28 Nov 2025 at BSE,NSE. Lead manager: ICICI Securities Ltd.. Key details for GMP, subscription, price, , and listing in one place.

Official documents:RHP
IPO detailsSubscriptionAllotmentListingPriceReviewsNews

Sudeep Pharma IPO overview

Sudeep Pharma IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹563 to ₹593
Lot size
25 shares / lot
Min investment
₹14,825

Sudeep Pharma IPO progress

Subscription, allotment, refund, share credit, and listing milestones.

Listed
  1. Issue opens

    Subscription opens

    21 Nov 2025

  2. Issue closes

    Last day to apply

    25 Nov 2025

  3. Allotment

    Allotment status out

    26 Nov 2025

  4. Refund / Share credit

    Refund initiated · Shares in demat

    27 Nov 2025

  5. Listing

    Trading begins

    28 Nov 2025

Sudeep Pharma IPO lot size

CategoryLotsSharesAmountProfit @ listing
Retail (Min)125₹14,825+₹3,425
Retail (Max)13325₹1,92,725+₹44,525
S-HNI (Min)14350₹2,07,550+₹47,950
S-HNI (UPI)33825₹4,89,225+₹1,13,025
S-HNI (Max)671,675₹9,93,275+₹2,29,475
B-HNI (Min)681,700₹10,08,100+₹2,32,900
SHA (Max)13325₹1,92,725+₹44,525

Profit based on the official listing price for each investor category.

Cut‑off within the price band is set after book‑building when applicable. SME issues often require at least two lots; mainboard retail typically bids one lot at cut‑off.

About Sudeep Pharma IPO

From the company / RHP narrative.

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries. The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium  The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients. Product Portfolio: Pharmaceutical, Food and Nutrition Business Specialty Ingredients Business Triturates As of December 31, 2024, the company had 704 permanent employees. Competitve Strengths: Market leadership with a diversified product portfolio in a high barrier industry Distinguished global customer base with long-standing relationships with key customers Well-equipped and regulatory compliant Manufacturing Facilities Strong research and development capabilities

Sudeep Pharma IPO Issue Objective

How the issuer plans to use IPO proceeds.

Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I General corporate purposes

Download the app

Follow the latest IPO & unlisted research on iOS and Android.

Google PlayApp Store

Documents & links

Prospectus, draft filings, and company site open in a new tab.

RHPDHRPCompany website

Issue details

Key details about the issue, including the face value, lot size, and minimum investment.

Issue Type
BB
Face Value
1
Lead Managers(2)
  • ICICI Securities Ltd.
  • IIFL Capital Services Ltd.
Min Quantity
25
Company Promoters(6)
  • Sujit Jaysukh Bhayani
  • Avani Sujit Bhayani
  • Shanil Sujit Bhayani
  • Sujeet Jaysukh Bhayani HUF
  • Riva Resources Private Limited
  • Bhayani Family Trust are the promoters of the company.
Website
https://www.sudeeppharma.com/
Email
cs.sudeep@sudeepgroup.com
Phone
+91 265 284 0656
Address
Sudeep Pharma Ltd. 129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340

Registrar details

Details about the registrar of the issue.

Registrar Name
MUFG Intime India Private Limited (Link Intime)
Email
ipo.helpdesk@in.mpms.mufg.com
Phone
2249186270
Address
Link Intime India Private Ltd C 101, 247 Park, L.B.S.Marg, Vikhroli (West), Mumbai - 400083
Website
https://in.mpms.mufg.com/home.html

Financial performance

Figures from the IPO financial table (₹ Cr). Switch metric to compare years.

Sudeep Pharma IPO

Loading chart…

Sudeep Pharma IPO Ratings & reviews

Community ratings and reviews — not financial advice.

No ratings yet — be the first to share your experience.

Sudeep Pharma IPO FAQs

A quick overview of key terms, dates, and how to track this IPO.

What is Sudeep Pharma IPO?

Sudeep Pharma IPO is a public issue where the company offers its shares to investors through the stock , allowing retail, HNI, and institutional participation.

What is the IPO price band of Sudeep Pharma IPO?

The IPO price band of Sudeep Pharma IPO is ₹₹563 to ₹593 per share, as mentioned in the issue details.

What is the minimum investment required for Sudeep Pharma IPO?

The minimum investment in Sudeep Pharma IPO is ₹14,825, based on the applicable lot size for retail investors.

What is the lot size of Sudeep Pharma IPO?

The lot size of Sudeep Pharma IPO is 25 shares per lot, and applications must be made in multiples of this lot size.

What are the opening and closing dates of Sudeep Pharma IPO?

Sudeep Pharma IPO opens on 21 Nov 2025 and closes on 25 Nov 2025, as per the announced schedule.

What is Sudeep Pharma IPO subscription status?

Sudeep Pharma IPO subscription status shows the level of demand across retail, HNI, and institutional investor categories during the issue period.

What is Sudeep Pharma IPO GMP today?

Sudeep Pharma IPO GMP (Grey Market Premium) today is around ₹TBA, reflecting current grey market activity before listing.

Is Sudeep Pharma IPO GMP positive or negative?

Sudeep Pharma IPO GMP is currently subject to change, based on prevailing grey market trends. GMP may change over time.

What does Sudeep Pharma IPO GMP indicate for listing?

A positive Sudeep Pharma IPO GMP may indicate market interest ahead of listing, while actual listing performance depends on subscription response and market conditions.

When is Sudeep Pharma IPO listing date?

The expected listing date of Sudeep Pharma IPO is 28 Nov 2025, subject to completion of the process.

Where can I check Sudeep Pharma IPO allotment status?

Sudeep Pharma IPO status can be checked online once the process is completed using application or PAN details.

Can Sudeep Pharma IPO subscription and GMP change before listing?

Yes, Sudeep Pharma IPO subscription figures and GMP may change during the issue period and before listing based on market activity.